PENTAX Medical 2025: C2 CryoBalloon Line Sold to Merit Medical
October 16, 2025 | 16:02
The asset transfer signals a strategic pivot toward endoscopic imaging rather than ablative therapy, reflecting broader portfolio rationalisation in gastro-enterology.
Mobile Version